ATE474044T1 - Antikörper und ihre verwendung - Google Patents

Antikörper und ihre verwendung

Info

Publication number
ATE474044T1
ATE474044T1 AT99919662T AT99919662T ATE474044T1 AT E474044 T1 ATE474044 T1 AT E474044T1 AT 99919662 T AT99919662 T AT 99919662T AT 99919662 T AT99919662 T AT 99919662T AT E474044 T1 ATE474044 T1 AT E474044T1
Authority
AT
Austria
Prior art keywords
ligand
activity
modulating activity
derivative
monoclonal antibodies
Prior art date
Application number
AT99919662T
Other languages
English (en)
Inventor
Hirokazu Matsumoto
Chieko Kitada
Shuji Hinuma
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of ATE474044T1 publication Critical patent/ATE474044T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT99919662T 1998-05-21 1999-05-20 Antikörper und ihre verwendung ATE474044T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14029398 1998-05-21
PCT/JP1999/002650 WO1999060112A1 (fr) 1998-05-21 1999-05-20 Anticorps et leur utilisation

Publications (1)

Publication Number Publication Date
ATE474044T1 true ATE474044T1 (de) 2010-07-15

Family

ID=15265429

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99919662T ATE474044T1 (de) 1998-05-21 1999-05-20 Antikörper und ihre verwendung

Country Status (7)

Country Link
US (2) US7067268B1 (de)
EP (1) EP1081222B1 (de)
AT (1) ATE474044T1 (de)
AU (1) AU3733199A (de)
CA (1) CA2328416C (de)
DE (1) DE69942580D1 (de)
WO (1) WO1999060112A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2380573A1 (en) * 1999-08-03 2001-02-08 Oy Juvantia Pharma Ltd. Prolactin-releasing peptide and method for regulating autonomic functions and treating pain

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE335818T1 (de) 1995-12-28 2006-09-15 Takeda Pharmaceutical Ligand polypeptide für hypophyse g-protein gekoppeltes rezeptor-protein, deren herstellung und anwendung
CA2285628A1 (en) 1997-04-28 1998-11-05 Takeda Chemical Industries, Ltd. Ligand polypeptide for the g protein-coupled receptor from human pituitary glands
EP0887417A3 (de) 1997-06-27 1999-01-13 Takeda Chemical Industries, Ltd. Verfahren zur Herstellung von einem 19P2-Liganden mittels Spaltung eines diesen Liganden enthaltenden Fusionsproteins

Also Published As

Publication number Publication date
CA2328416A1 (en) 1999-11-25
US20050158795A1 (en) 2005-07-21
WO1999060112A1 (fr) 1999-11-25
DE69942580D1 (de) 2010-08-26
EP1081222A1 (de) 2001-03-07
CA2328416C (en) 2010-02-09
AU3733199A (en) 1999-12-06
EP1081222B1 (de) 2010-07-14
EP1081222A4 (de) 2005-03-02
US7067268B1 (en) 2006-06-27
US7598351B2 (en) 2009-10-06

Similar Documents

Publication Publication Date Title
ES556865A0 (es) Un metodo de inmunoensayo.
ATE555130T1 (de) Il-18-bindende proteine
PT921395E (pt) Ensaio para medicao de fragmentos de proteina em meios biologicos
ATE504601T1 (de) Anti-cd3-antikörper zur verwendung zur induzierung von immunsuppression
NL300387I1 (nl) Antilichaam tegen menselijke interleukine-6-receptor
PT1322960E (pt) Ensaio de micro-arranjos de alergenios
TR200002731T2 (tr) Proteolitik antikorların indüktör ve inhibitörlerinin tanımlanması, kompozisyonları ve kullanımları için metotlar
DK1887014T3 (da) Humane Toll-homologer
DE69133179D1 (de) Katalytische antikörperkomponente
DK1111385T3 (da) Enzym-protein-kompleks
DE69418284D1 (de) Vorrichtung zur analyse von haptenen und ihre verwendung
ES2072423T3 (es) Anticuerpo monoclonal e inmunoensayo para el factor beta xiia de coagulacion de la sangre.
ATE474044T1 (de) Antikörper und ihre verwendung
DE3850993D1 (de) Monoklonaler Antikörper spezifisch gegen humane Pankreas-Phospholipase-A2.
EP0269677A4 (de) Testverfahren und antikörper für n-myc-proteine.
DE69523492D1 (de) Immunoassay-Reagenzien, Testsätze und Verfahren
ES2173879T3 (es) Procedimiento para la preparacion de conjugados a base de un participe especifico en la fijacion y de una proteina que contiene hidratos de carbono
EP1572931A4 (de) Verfahren und zusammensetzungen zur modulation und zum nachweis von wisp-aktivität
Rose et al. Ceftiofur sodium: monoclonal antibody development and cross-reactivity studies with structurally related cephalosporins
FR2759296B1 (fr) Complexe non-covalent comprenant au moins un anticorps et un element de liaison aux immunoglobulines associe a une substance active, son procede de preparation et ses applications
DE3785175D1 (de) A-assoziierte h-antigene, spezifische monoklonale antikoerper und methoden zu deren verwendung zur blutgruppenbestimmung.
ATE144286T1 (de) Monoklonale antikörper gegen den plasmin- antiplasmin komplex, verfahren zu ihrer herstellung sowie ihre verwendung
WO2004065936A3 (en) Immunoglobulin e detection in mammalian species
WO2005077978A3 (de) Antikörper zur diagnose und behandlung von neuropsychiatrischen erkrankungen, insbesondere von schizophrenie, depression und bipolaren affektiven störungen
ATE405646T1 (de) Ein verfahren zum auffinden vom prostatakrebs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties